BSEAccretion Nutraveda LtdMediumNeutral
Announced Fri, 8 May · 19:41 IST

Please find enclosed herewith Appointment of Ms. Grishma A Shewale as an Additional Non - Executive Independent Director of the Company.

Multiple Ind Directors ResignedManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹283.00
prior close
₹250.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-2.9-7.8-3.9-8.1-7.1-9.2-8.4
Up moveDown movePending
AI summary

Accretion Nutraveda reported strong FY2025-26 results with revenue up 110% to ₹3,360.31 lakhs and net profit of ₹506.83 lakhs (vs ₹250.09 lakhs). The company listed on BSE SME in February 2026 and has utilized ₹1,821.32 lakhs of its ₹2,476.80 lakh IPO proceeds. Two independent directors (Mr. Arun Dash and Mr. Mahipal Singh Chouhan) resigned on May 8, citing personal and professional commitments. They were replaced by appointing Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale as Additional Independent Directors, both for 5-year terms subject to shareholder approval. Sakhiya & Co. was reappointed as secretarial auditor and U M T & Co. appointed as internal auditor for FY 2026-27.

Likely market impact

The dual resignation of independent directors on the same day raises governance concerns despite the company immediately filling both positions. Investors should monitor whether the new appointments are approved at the upcoming AGM and assess board independence going forward.